Discovery and structure-activity relationship of a novel spirocarbamate series of NPY Y5 antagonists
被引:6
作者:
Leslie, Colin P.
论文数: 0引用数: 0
h-index: 0
机构:
GlaxoSmithKline SpA, Med Res Ctr, Neurosci Ctr Excellence Drug Discovery, I-37135 Verona, ItalyGlaxoSmithKline SpA, Med Res Ctr, Neurosci Ctr Excellence Drug Discovery, I-37135 Verona, Italy
Leslie, Colin P.
[1
]
Bentley, Jonathan
论文数: 0引用数: 0
h-index: 0
机构:
GlaxoSmithKline SpA, Med Res Ctr, Neurosci Ctr Excellence Drug Discovery, I-37135 Verona, ItalyGlaxoSmithKline SpA, Med Res Ctr, Neurosci Ctr Excellence Drug Discovery, I-37135 Verona, Italy
Bentley, Jonathan
[1
]
Biagetti, Matteo
论文数: 0引用数: 0
h-index: 0
机构:
GlaxoSmithKline SpA, Med Res Ctr, Neurosci Ctr Excellence Drug Discovery, I-37135 Verona, ItalyGlaxoSmithKline SpA, Med Res Ctr, Neurosci Ctr Excellence Drug Discovery, I-37135 Verona, Italy
Biagetti, Matteo
[1
]
Contini, Stefania
论文数: 0引用数: 0
h-index: 0
机构:
GlaxoSmithKline SpA, Med Res Ctr, Neurosci Ctr Excellence Drug Discovery, I-37135 Verona, ItalyGlaxoSmithKline SpA, Med Res Ctr, Neurosci Ctr Excellence Drug Discovery, I-37135 Verona, Italy
Contini, Stefania
[1
]
Di Fabio, Romano
论文数: 0引用数: 0
h-index: 0
机构:
GlaxoSmithKline SpA, Med Res Ctr, Neurosci Ctr Excellence Drug Discovery, I-37135 Verona, ItalyGlaxoSmithKline SpA, Med Res Ctr, Neurosci Ctr Excellence Drug Discovery, I-37135 Verona, Italy
Di Fabio, Romano
[1
]
Donati, Daniele
论文数: 0引用数: 0
h-index: 0
机构:
GlaxoSmithKline SpA, Med Res Ctr, Neurosci Ctr Excellence Drug Discovery, I-37135 Verona, ItalyGlaxoSmithKline SpA, Med Res Ctr, Neurosci Ctr Excellence Drug Discovery, I-37135 Verona, Italy
Donati, Daniele
[1
]
Genski, Thorsten
论文数: 0引用数: 0
h-index: 0
机构:
GlaxoSmithKline SpA, Med Res Ctr, Neurosci Ctr Excellence Drug Discovery, I-37135 Verona, ItalyGlaxoSmithKline SpA, Med Res Ctr, Neurosci Ctr Excellence Drug Discovery, I-37135 Verona, Italy
Genski, Thorsten
[1
]
Guery, Sebastien
论文数: 0引用数: 0
h-index: 0
机构:
GlaxoSmithKline SpA, Med Res Ctr, Neurosci Ctr Excellence Drug Discovery, I-37135 Verona, ItalyGlaxoSmithKline SpA, Med Res Ctr, Neurosci Ctr Excellence Drug Discovery, I-37135 Verona, Italy
Guery, Sebastien
[1
]
Mazzali, Angelica
论文数: 0引用数: 0
h-index: 0
机构:
GlaxoSmithKline SpA, Med Res Ctr, Neurosci Ctr Excellence Drug Discovery, I-37135 Verona, ItalyGlaxoSmithKline SpA, Med Res Ctr, Neurosci Ctr Excellence Drug Discovery, I-37135 Verona, Italy
Mazzali, Angelica
[1
]
Merlo, Giancarlo
论文数: 0引用数: 0
h-index: 0
机构:
GlaxoSmithKline SpA, Med Res Ctr, Neurosci Ctr Excellence Drug Discovery, I-37135 Verona, ItalyGlaxoSmithKline SpA, Med Res Ctr, Neurosci Ctr Excellence Drug Discovery, I-37135 Verona, Italy
Merlo, Giancarlo
[1
]
Pizzi, Domenica A.
论文数: 0引用数: 0
h-index: 0
机构:
GlaxoSmithKline SpA, Med Res Ctr, Neurosci Ctr Excellence Drug Discovery, I-37135 Verona, ItalyGlaxoSmithKline SpA, Med Res Ctr, Neurosci Ctr Excellence Drug Discovery, I-37135 Verona, Italy
Pizzi, Domenica A.
[1
]
Sacco, Fabiola
论文数: 0引用数: 0
h-index: 0
机构:
GlaxoSmithKline SpA, Med Res Ctr, Neurosci Ctr Excellence Drug Discovery, I-37135 Verona, ItalyGlaxoSmithKline SpA, Med Res Ctr, Neurosci Ctr Excellence Drug Discovery, I-37135 Verona, Italy
Sacco, Fabiola
[1
]
Seri, Catia
论文数: 0引用数: 0
h-index: 0
机构:
GlaxoSmithKline SpA, Med Res Ctr, Neurosci Ctr Excellence Drug Discovery, I-37135 Verona, ItalyGlaxoSmithKline SpA, Med Res Ctr, Neurosci Ctr Excellence Drug Discovery, I-37135 Verona, Italy
Seri, Catia
[1
]
Tessari, Michela
论文数: 0引用数: 0
h-index: 0
机构:
GlaxoSmithKline SpA, Med Res Ctr, Neurosci Ctr Excellence Drug Discovery, I-37135 Verona, ItalyGlaxoSmithKline SpA, Med Res Ctr, Neurosci Ctr Excellence Drug Discovery, I-37135 Verona, Italy
Tessari, Michela
[1
]
Zonzini, Laura
论文数: 0引用数: 0
h-index: 0
机构:
GlaxoSmithKline SpA, Med Res Ctr, Neurosci Ctr Excellence Drug Discovery, I-37135 Verona, ItalyGlaxoSmithKline SpA, Med Res Ctr, Neurosci Ctr Excellence Drug Discovery, I-37135 Verona, Italy
Zonzini, Laura
[1
]
Caberlotto, Laura
论文数: 0引用数: 0
h-index: 0
机构:
GlaxoSmithKline SpA, Med Res Ctr, Neurosci Ctr Excellence Drug Discovery, I-37135 Verona, ItalyGlaxoSmithKline SpA, Med Res Ctr, Neurosci Ctr Excellence Drug Discovery, I-37135 Verona, Italy
Caberlotto, Laura
[1
]
机构:
[1] GlaxoSmithKline SpA, Med Res Ctr, Neurosci Ctr Excellence Drug Discovery, I-37135 Verona, Italy
A novel series of trans-8-aminomethyl-1-oxa-3-azaspiro[4.5] decan-2-one derivatives was identified with potent NPY Y5 antagonist activity. Optimization of the original lead furnished compounds 23p and 23u, which combine sub-nanomolar Y5 activity with metabolic stability, oral bioavailability, brain penetration and strong preclinical profile for development. Both compounds significantly inhibited the food intake induced by a Y5 selective agonist with minimal effective doses of 3 mg/kg po. (C) 2010 Elsevier Ltd. All rights reserved.